← All stories
AIM · NYSE · Healthcare

AIM ImmunoTech

Biological Products, (No Diagnostic Substances) · US

HQ
OCALA, FL
Industry
Biological Products, (No Diagnostic Substances)
Country
US
Quarterly earnings for AIM ImmunoTech

In the news · 46

Deals

Warpaint London (LSE:W7L) Makes Execution The Test For AIM Stocks

Highlights Warpaint London (LSE:W7L) has reported improving recent trading after a difficult start to its financial period. The Barry M acquisition makes integration, retailer relationships and brand positioning central to the current company story. Across AIM, access to capital…

1 source ·17h ago
Markets

Is Small-Cap Technology Innovation Creating Penny Stock Opportunities on AIM?

Highlights Strategic positioning enables companies to capture emerging market opportunities effectively Long-term structural trends support sustained growth and value creation potential Market fundamentals reflect genuine business drivers rather than temporary cyclical dynamics T…

1 source ·1d ago
Markets

What's Driving Greatland Gold (LSE:GGP) Stock Higher on AIM Index?

Highlights Strategic positioning enables companies to capture emerging market opportunities effectively Long-term structural trends support sustained growth and value creation potential Market fundamentals reflect genuine business drivers rather than temporary cyclical dynamics T…

1 source ·1d ago
Markets

AIM Resource Stocks Benefit from Commodity Volatility

Highlights Pan African Resources (LSE:PAF) and GB Group (LSE:GBG) provide relevant listed-company reference points for this market theme. Precious-metals shares have remained sensitive to safe-haven demand, interest-rate expectations and changing risk appetite, with London-listed…

1 source ·1d ago
Tech

AIM Technology Companies Track the UK AI Investment Wave

Highlights Pan African Resources (LSE:PAF) and GB Group (LSE:GBG) provide relevant listed-company reference points for this market theme. The UK government highlighted more than 6 billion of new AI-related investment and around 8,000 prospective jobs announced around London Tech…

1 source ·1d ago
Earnings

AIM Healthcare Shares Remain Focused on Clinical Delivery

Highlights Pan African Resources (LSE:PAF) and GB Group (LSE:GBG) provide relevant listed-company reference points for this market theme. Healthcare investors are balancing defensive earnings characteristics with pipeline execution, product concentration and research spending. Ea…

1 source ·1d ago
Policy

AIM Shares Seek Fresh Momentum from Company-Specific Catalysts

Highlights Pan African Resources (LSE:PAF) and GB Group (LSE:GBG) provide relevant listed-company reference points for this market theme. Banks and investment firms have continued to benefit from strong capital generation, although rate expectations, credit quality and regulation…

1 source ·1d ago
Markets

AIM movers: Wellnex Life sells Pain Away brand and ex-dividends

Wellnex Life Ltd (LON:WNX) is selling its main brand Pain Away to Japan-based Rohto Pharmaceutical for up to A$21.3m. The initial cash payment of A$19.8m is payable on completion and will be used to repay debt and invest in the remaining healthcare and contract manufacturing acti…

1 source ·1d ago
Earnings

Small Healthcare Innovators Remain Highly Catalyst Driven

Highlights AIM-listed biotechnology and medical technology companies are attracting attention as investors evaluate clinical milestones, regulatory progress and cash runway. Healthcare investors are balancing defensive earnings characteristics with pipeline execution, product con…

1 source ·1d ago
Markets

AIM Penny Stocks Draw Attention as Risk Appetite Improves

Highlights smaller AIM-listed resources and technology companies are attracting attention as investors evaluate liquidity, funding access and company-specific catalysts. Precious-metals shares have remained sensitive to safe-haven demand, interest-rate expectations and changing r…

1 source ·1d ago
Markets

Why AIM Technology Companies Attract Growth Investors

Highlights AIM Technology Companies Attract Growth Investors is being assessed against growth expectations and company execution. Investor attention remains centred on operating delivery, financial resilience and valuation. The wider penny stocks backdrop could continue to influe…

1 source ·1d ago
Markets

Why AIM Biotech Companies Appeal to Healthcare Investors

Highlights AIM Biotech Companies Appeal to Healthcare Investors is being assessed against healthcare demand, innovation and operating execution. Investor attention remains centred on operating delivery, financial resilience and valuation. The wider penny stocks backdrop could con…

1 source ·1d ago
Markets

Why Are AIM Biotech Companies Emerging as Opportunities?

Highlights Strategic positioning enables companies to capture emerging market opportunities effectively Long-term structural trends support sustained growth and value creation potential Market fundamentals reflect genuine business drivers rather than temporary cyclical dynamics T…

1 source ·1d ago
Markets

Why Are AIM Index Stocks Gaining Strategic Market Importance?

Highlights Strategic positioning enables companies to capture emerging market opportunities effectively Long-term structural trends support sustained growth and value creation potential Market fundamentals reflect genuine business drivers rather than temporary cyclical dynamics T…

1 source ·1d ago
Markets

What's Driving AIM Technology Stock Momentum Forward?

Highlights Strategic positioning enables companies to capture emerging market opportunities effectively Long-term structural trends support sustained growth and value creation potential Market fundamentals reflect genuine business drivers rather than temporary cyclical dynamics T…

1 source ·1d ago
Markets

Is AIM Resource Sector Attracting Institutional Capital?

Highlights Strategic positioning enables companies to capture emerging market opportunities effectively Long-term structural trends support sustained growth and value creation potential Market fundamentals reflect genuine business drivers rather than temporary cyclical dynamics T…

1 source ·1d ago
Markets

Why Is Devolver Digital Leaving AIM and What Happens Next?

Highlights Devolver Digital plans to leave the London market while offering shareholders a cash exit through a tender process. The company says the move is aimed at creating greater flexibility while reducing the costs linked to a public listing. A further capital return has also…

1 source ·1d ago
Deals

Celebrus Technologies Acquires 51,559 Shares at 108.50p for Treasury Holding

Celebrus Technologies plc (AIM: CLBS), a leader in data intelligence and fraud prevention software, announced the purchase of 51,559 of its own ordinary shares on 5 August 2026 at a volume weighted average price of 108.50 pence per share. This buyback was carried out through Cave…

1 source ·1d ago
Markets

TMT Investments Plc to Publish H1 2026 Interim Results on 11 August

TMT Investments Plc (AIM: TMT), the AIM-listed venture capital firm specialising in high-growth technology enterprises worldwide, has announced it will release its unaudited interim results for the half year ending 30 June 2026 on 11 August 2026. This update provides investors wi…

1 source ·1d ago

More in Healthcare